Quantbot Technologies LP Has $2.21 Million Holdings in Globe Life Inc. (NYSE:GL)

Quantbot Technologies LP grew its holdings in Globe Life Inc. (NYSE:GL) by 115.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,809 shares of the company’s stock after purchasing an additional 10,611 shares during the quarter. Quantbot Technologies LP’s holdings in Globe Life were worth $2,209,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Versant Capital Management Inc boosted its stake in shares of Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after purchasing an additional 194 shares during the last quarter. Albion Financial Group UT bought a new position in shares of Globe Life in the 4th quarter valued at about $28,000. Rakuten Securities Inc. bought a new position in shares of Globe Life in the 4th quarter valued at about $28,000. Avalon Trust Co bought a new position in shares of Globe Life in the 4th quarter valued at about $41,000. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Globe Life by 32.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company’s stock valued at $41,000 after purchasing an additional 90 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

GL has been the topic of several recent analyst reports. Morgan Stanley lifted their price objective on shares of Globe Life from $125.00 to $126.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. BMO Capital Markets initiated coverage on shares of Globe Life in a research note on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price objective on the stock. Jefferies Financial Group lifted their price objective on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research note on Tuesday, December 10th. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of Globe Life from $137.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 12th. Five equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Globe Life presently has an average rating of “Moderate Buy” and a consensus target price of $135.60.

Insider Activity

In other news, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now directly owns 5,122 shares in the company, valued at $579,964.06. This trade represents a 36.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO James Matthew Darden sold 24,890 shares of the business’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the transaction, the chief executive officer now owns 38,973 shares in the company, valued at approximately $4,735,998.96. The trade was a 38.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 61,338 shares of company stock worth $7,239,630 over the last ninety days. Insiders own 1.51% of the company’s stock.

Globe Life Stock Performance

Shares of GL opened at $126.86 on Monday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. Globe Life Inc. has a twelve month low of $38.95 and a twelve month high of $131.39. The firm’s 50 day moving average price is $122.53 and its two-hundred day moving average price is $113.03. The firm has a market cap of $10.64 billion, a P/E ratio of 10.62 and a beta of 0.77.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. On average, analysts forecast that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Thursday, April 3rd will be issued a $0.27 dividend. The ex-dividend date of this dividend is Thursday, April 3rd. This is an increase from Globe Life’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.85%. Globe Life’s dividend payout ratio (DPR) is 9.04%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.